on 16 Jul 2024
Last Applicant/ Owned by
1-5-1, Wakinohama-kaigandori, Chuo-ku,
Kobe, Hyogo
JP
651-0073
Serial Number
97821655 filed on 03rd Mar 2023
Registration Number
7446059 registered on 16th Jul 2024
Correspondent Address
Jonathan Brown
Filing Basis
1. intent to use
Disclaimer
NO DATA
Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; testing, inspection or research of medical apparatus or instruments; medical research; Scientific research in the nature of conducting clinical trials for others; scientific research; stem cell research services apparatus for the regeneration of stem cells for medical purposes; blood transfusion apparatus for medical pur Read More
Providing medical information; regenerative medicine services; health care services, namely, therapy and diagnostic services using regenerative medicine; health care services, namely, therapy and diagnostic services using cell therapy; blood and tissue bank services, namely, collection and preservation of biological tissue, blood, and cells; stem cell bank services; medical services relating to the removal, treatment and processing of human cells; medical services relating to the removal, treatment and processing of human blood
N/A
N/A
Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; testing, inspection or research of medical apparatus or instruments; medical research; Scientific research in the nature of conducting clinical trials for others; scientific research; stem cell research services
N/A
N/A
retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services featuring chemicals; retail store services featuring medical apparatus or instruments
N/A
N/A
apparatus for the regeneration of stem cells for medical purposes; blood transfusion apparatus for medical purposes; medical tubing for transfusions
N/A
N/A
Custom manufacture or production of pharmaceuticals; custom manufacture or production of pharmaceutical materials; Custom manufacture or production of chemicals; custom manufacture of medical devices for others; custom manufacture of scientific devices for others
N/A
N/A
Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer or blood diseases; biological tissue cultures for medical purposes; pharmaceutical preparations or biological preparations for diagnostic or medical purposes, namely, pharmaceutical and biological preparations for the treatment of cancer or blood diseases; regenerative medical products, namely blood preparations using stem cells; stem cells for medical purposes; stem cells for veterinary purposes; regenerative medical products of stem cells, namely blood-derived products; pharmaceutical preparations of stem cells, namely, pharmaceutical preparations of stem cells derived from umbilical cord blood or peripheral blood and expanded in culture for use in stem cell transplantation and regenerative therapy, in medical or clinical use; transplants, being living tissues, for medical use, namely, gene therapy products, namely, genetically engineered tissues for transplant purposes; cells for medical use; blood preparations for medical purposes, namely, blood substitute for medical use; diagnostic reagents for medical purposes; chemical reagents for medical purposes
N/A
N/A
No 97821655
No Service Mark
No 11333/1162
Yes
No
No
Yes
No
No
No
No
26.01.03 -
Incomplete circles (more than semi-circles)
26.01.21 -
Circles that are totally or partially shaded
26.05.21 -
Triangles that are completely or partially shaded
Status Date | Action Taken |
---|---|
16th Jul 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
16th Jul 2024 | REGISTERED-PRINCIPAL REGISTER |
30th Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
30th Apr 2024 | PUBLISHED FOR OPPOSITION |
10th Apr 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
27th Mar 2024 | CASE RETURNED TO EXAMINATION |
27th Mar 2024 | NOTICE OF ALLOWANCE CANCELLED |
05th Feb 2024 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
05th Feb 2024 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
31st Jan 2024 | ASSIGNED TO PETITION STAFF |